Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coagulation and anticoagulation in COVID-19
Tarik Hadid, Zyad Kafri, Ayad Al-Katib
Blood Reviews (2020) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Long-term complications of COVID-19
Amar D. Desai, Michael P. Lavelle, Brian C. Boursiquot, et al.
AJP Cell Physiology (2021) Vol. 322, Iss. 1, pp. C1-C11
Open Access | Times Cited: 350
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Dounia Darif, Ikram Hammi, Ayyoub Kihel, et al.
Microbial Pathogenesis (2021) Vol. 153, pp. 104799-104799
Open Access | Times Cited: 277
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Yi-Zhou Jiang, Limor Rubin, Tangming Peng, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 459-472
Open Access | Times Cited: 107
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Vascular “Long COVID”: A New Vessel Disease?
Giada Zanini, Valentina Selleri, Luca Roncati, et al.
Angiology (2023) Vol. 75, Iss. 1, pp. 8-14
Open Access | Times Cited: 48
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness
Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 07, pp. 858-868
Open Access | Times Cited: 42
Clinical features of thrombosis and bleeding in COVID-19
Mari R. Thomas, Marie Scully
Blood (2022) Vol. 140, Iss. 3, pp. 184-195
Open Access | Times Cited: 41
Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities
Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 39
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, et al.
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1307-1322
Open Access | Times Cited: 23
Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review
Paschalis Karakasis, Athina Nasoufidou, Μarios Sagris, et al.
Life (2024) Vol. 14, Iss. 5, pp. 545-545
Open Access | Times Cited: 8
ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients
Simone G. Ramos, Bruna Rattis, Giulia Ottaviani, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 7, pp. 1154-1164
Open Access | Times Cited: 50
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Denisa Bojková, Rui Costa, Philipp Reus, et al.
Metabolites (2021) Vol. 11, Iss. 10, pp. 699-699
Open Access | Times Cited: 40
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 296-296
Open Access | Times Cited: 35
Venous thromboembolism in viral diseases: A comprehensive literature review
Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 15
Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers
Rasoul Ebrahimi, Fatemeh Nasri, Tahereh Kalantari
Annals of Hematology (2024) Vol. 103, Iss. 6, pp. 1819-1831
Closed Access | Times Cited: 5
Hypercoagulability in COVID-19
Ryan Geffin, Likhita Nandigam, Mayra L. Mesa, et al.
Elsevier eBooks (2025), pp. 387-407
Closed Access
D-dimer in systemic circulation and COVID-19 outcome
Likhita Nandigam, Maria Antonia Rico Mesa, Ryan Geffin, et al.
Elsevier eBooks (2025), pp. 369-385
Closed Access
Comparison of management options for spontaneous bleeding into soft tissues in patients with COVID-19
A E Tyagunov, D. Yu. Trudkov, A. Yu. Polyaev, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Erbin Regulates Tissue Factors Through Ras/Raf Pathway in Coagulation Disorders in Sepsis
Cheng Yang, Chuntian Lei, Guoqing Jing, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1739-1754
Open Access
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access
Altered platelet and coagulation function in moderate-to-severe COVID-19
Rustem I. Litvinov, Natalia G. Evtugina, Alina D. Peshkova, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
Ayat Zawawi, Abdallah Y. Naser, Hassan Alwafi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients
Rasha Abu Eid, Frank J. Ward
Immunology Letters (2021) Vol. 240, pp. 1-8
Open Access | Times Cited: 35
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 948-948
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top